ID: ALA177777

Max Phase: Preclinical

Molecular Formula: C9H22N2O2S

Molecular Weight: 222.35

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CS(=O)(=O)NCCCCCCCCN

Standard InChI:  InChI=1S/C9H22N2O2S/c1-14(12,13)11-9-7-5-3-2-4-6-8-10/h11H,2-10H2,1H3

Standard InChI Key:  KJHSAWIVYYPQBP-UHFFFAOYSA-N

Associated Targets(Human)

Polyamine oxidase 84 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 222.35Molecular Weight (Monoisotopic): 222.1402AlogP: 0.83#Rotatable Bonds: 9
Polar Surface Area: 72.19Molecular Species: BASEHBA: 3HBD: 2
#RO5 Violations: 0HBA (Lipinski): 4HBD (Lipinski): 3#RO5 Violations (Lipinski): 0
CX Acidic pKa: 12.09CX Basic pKa: 10.20CX LogP: 0.15CX LogD: -2.36
Aromatic Rings: 0Heavy Atoms: 14QED Weighted: 0.57Np Likeness Score: -0.67

References

1. Dredar SA, Blankenship JW, Marchant PE, Manneh V, Fries DS..  (1989)  Design and synthesis of inhibitors of N8-acetylspermidine deacetylase.,  32  (5): [PMID:2709384] [10.1021/jm00125a010]

Source